The time to embrace emerging markets is now
It’s happening. In fact, it’s already happened. The pharma industry is hurtling headlong into emerging markets with incredible passion and energy. Emerging markets aren’t just the future of the pharma […]
BRANDKARMA THOUGHTS
Brand dogma for building new healthcare brands – Part 2
Healthcare brands are a veritable smorgasbord of tangible and intangible attributes. Manage them effectively and you can create: Value Relevancy Influence Equity One of the biggest pitfalls I see is […]
Brand dogma for building new healthcare brands – Part 1
There’s something magical about launching a new healthcare brand. Maybe it’s the thrill of starting from a blank slate or the potential for prominence. Whatever the impetus, this two-part series […]
The Struggle for Consumer Attention: Brand-Name Drugs vs. Generics
When consumers believe two products to be exact replicas of one another, it makes sense for them to choose the less expensive option. This theory applies to the pharmaceutical world […]
Part 3: The ACA, Dr. Donald Berwick, and Inspiring Change in Behavior
Logical incentives, matched with emotional appeals and strict guidance, proved to be a lethal combination that inspired behavioral change among Dr. Berwick’s audiences. Initial participants were experiencing improvements in patient […]
The critical success factor for peer-to-peer presentations is the content delivery
Think of the last speakers’ training meeting you attended, or perhaps organized. As always, prior to the live meeting, draft presentations and key references are supposed to be shipped before […]
